📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts. (2020)

First Author: Shiu KY

Attributed to: King’s College London Confidence in Concept 2018 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.00079

PubMed Identifier: 32117242

Publication URI: http://europepmc.org/abstract/MED/32117242

Type: Journal Article/Review

Volume: 11

Parent Publication: Frontiers in immunology

ISSN: 1664-3224